y 27632 has been researched along with Bone Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiadini, V; Manara, MC; Picci, P; Pinca, RS; Scotlandi, K; Zucchini, C | 1 |
Harimaya, K; Iwamoto, Y; Matsuda, S; Matsumoto, Y; Nakatani, F; Tanaka, K | 1 |
2 other study(ies) available for y 27632 and Bone Neoplasms
Article | Year |
---|---|
Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.
Topics: Amides; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Differentiation; Cell Movement; Cell Proliferation; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Pyridines; rho-Associated Kinases; Sarcoma, Ewing; Tumor Cells, Cultured | 2017 |
Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Topics: Actins; Amides; Bone Neoplasms; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Osteosarcoma; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Tyrosine | 2001 |